Search Results 171-180 of 16382 for infliximab

  1. Siltuximab (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  2. What is Mayo Clinic’s approach to surgical treatment for IBD?

    Eric Dozois, M.D., Colon and Rectal Surgeon: Inflammatory bowel disease is made up really of two separate conditions. One is ulcerative colitis and the other is ...

  3. Clinical Trials - Statins for the Treatment of NASH

    Immune modulatory agents including systemic steroids, methotrexate, anti-TNF-? therapies (infliximab, adalimumab, etanercept) or anti-integrin therapy

  4. Adalimumab-ryvk (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-ryvk injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis. It is used in children 2 years ...

  5. Adalimumab-adaz (subcutaneous route) - Mayo Clinic

    Adalimumab-adaz injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  6. Ustekinumab-kfce (intravenous route, subcutaneous route) - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus Vaccine, Live; Poliovirus Vaccine, Live; Rotavirus Vaccine, Live; Rubella ...

  7. Tofacitinib (oral route) - Side effects & dosage - Mayo Clinic

    Infliximab; Influenza Virus Vaccine, Live; Letermovir; Lumacaftor; Measles Virus Vaccine, Live; Mifepristone; Mitotane; Mumps Virus Vaccine, Live; Nirmatrelvir ...

  8. Natalizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab; Vedolizumab. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

  9. TD-1473 for Active Ulcerative Colitis (UC) - Mayo Clinic

    ... infliximab, golimumab, etanercept, or certolizumab within the 60 days prior to Day 1, c) intravenous corticosteroids within the 14 days prior to Day 1, d ...

  10. Tocilizumab In The Treatment Of Refractory Polymyositis And Dermatomyositis - Mayo Clinic

    8 week washout for infliximab or adalimumab; 2 week washout for etanercept; 1 week washout for anakinra. If an IS agent is continued, the dose must remain ...